We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
Cap. Flow
+$512M
Cap. Flow %
1.04%
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85

Sector Composition

Rank Sector Weight
1 Financials 16.9%
2 Technology 16.24%
3 Healthcare 13.01%
4 Industrials 10.83%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCBG icon
2476
Capital City Bank Group
CCBG
$882M
$296K ﹤0.01%
12,882
-1,850
-13% -$44.9K
INO icon
2477
Inovio Pharmaceuticals
INO
$54M
$296K ﹤0.01%
5,976
-576
-9% -$35.7K
PFIS icon
2478
Peoples Financial Services
PFIS
$712M
$296K ﹤0.01%
6,354
-1,211
-16% -$57K
BW icon
2479
Babcock & Wilcox
BW
$1.41B
$295K ﹤0.01%
5,200
-824
-14% -$37.4K
FFH
2480
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
$294K ﹤0.01%
554
-1
-0.2% -$531
ASPS icon
2481
Altisource Portfolio Solutions
ASPS
$58.8M
$293K ﹤0.01%
1,309
-273
-17% -$58.4K
LQDT icon
2482
Liquidity Services
LQDT
$1.19B
$293K ﹤0.01%
60,370
+8,008
+15% +$43.6K
ARD
2483
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$292K ﹤0.01%
13,832
-200
-1% -$4.11K
PRMW
2484
DELISTED
Primo Water Corporation
PRMW
$292K ﹤0.01%
23,229
-4,171
-15% -$50K
AXTI icon
2485
AXT Inc
AXTI
$3.07B
$291K ﹤0.01%
33,475
-6,649
-17% -$60.8K
AAIC
2486
DELISTED
Arlington Asset Investment Corp.
AAIC
$290K ﹤0.01%
24,654
-3,435
-12% -$41.4K
MLR icon
2487
Miller Industries
MLR
$569M
$288K ﹤0.01%
11,172
-2,200
-16% -$59.6K
KDNY
2488
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$288K ﹤0.01%
7,687
-1,419
-16% -$62K
FTD
2489
DELISTED
FTD Companies, Inc. Common Stock
FTD
$287K ﹤0.01%
39,886
+5,417
+16% +$50.3K
CDZI icon
2490
Cadiz
CDZI
$264M
$286K ﹤0.01%
20,080
-3,734
-16% -$49.3K
RETA
2491
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$285K ﹤0.01%
10,065
+138
+1% +$3.85K
INAP
2492
DELISTED
Internap Corporation
INAP
$285K ﹤0.01%
+18,138
New +$308K
KEYW
2493
DELISTED
The KEYW Holding Corporation
KEYW
$285K ﹤0.01%
48,467
-8,003
-14% -$50.1K
OFLX icon
2494
Omega Flex
OFLX
$292M
$283K ﹤0.01%
3,966
-475
-11% -$31.5K
RDI icon
2495
Reading International Class A
RDI
$32.9M
$283K ﹤0.01%
16,935
-2,950
-15% -$46.3K
ONDK
2496
DELISTED
On Deck Capital, Inc.
ONDK
$280K ﹤0.01%
48,712
-9,500
-16% -$48.7K
PBPB
2497
DELISTED
Potbelly
PBPB
$279K ﹤0.01%
22,650
-4,396
-16% -$54K
TREC
2498
DELISTED
Trecora Resources
TREC
$279K ﹤0.01%
20,692
-3,570
-15% -$45.2K
OXFD
2499
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$279K ﹤0.01%
19,946
-4,079
-17% -$59.8K
CLNE icon
2500
Clean Energy Fuels
CLNE
$425M
$278K ﹤0.01%
136,896
-24,392
-15% -$53.9K

Similar funds

RhumbLine Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
  • RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
  • RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
  • RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
  • RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.

Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.